{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T11:26:46Z","timestamp":1787225206582,"version":"build-2736575974"},"reference-count":29,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303590"],"award-info":[{"award-number":["82303590"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Youth Innovation Team Development Program of Shandong Province","award":["2023KJ227"],"award-info":[{"award-number":["2023KJ227"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025T180977 and 2023M741867"],"award-info":[{"award-number":["2025T180977 and 2023M741867"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Postdoctoral Innovation Program of Shandong Province","award":["SDCX-ZG-202400078"],"award-info":[{"award-number":["SDCX-ZG-202400078"]}]},{"DOI":"10.13039\/100018936","name":"Qingdao Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["QDBSH20230202076"],"award-info":[{"award-number":["QDBSH20230202076"]}],"id":[{"id":"10.13039\/100018936","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Enzyme Inhibition and Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/14756366.2026.2717975","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T10:57:48Z","timestamp":1787223468000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Conformationally constrained 6\u2011aryl\u20111\u2011(3,4,5\u2011trimethoxyphenyl)-1\n                    <i>H<\/i>\n                    -pyrazolo[3,4\u2011b]pyrazines as novel microtubule destabilizers: design, synthesis, and antitumor evaluation"],"prefix":"10.1080","volume":"41","author":[{"given":"Zhu","family":"Guo","sequence":"first","affiliation":[{"name":"Department of Spinal Surgery, The Affiliated Hospital of Qingdao University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Affiliated Cardiovascular Hospital of Qingdao University, Qingdao University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zou","sequence":"additional","affiliation":[{"name":"The Affiliated Cardiovascular Hospital of Qingdao University, Qingdao University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiyun","family":"Sun","sequence":"additional","affiliation":[{"name":"The Affiliated Cardiovascular Hospital of Qingdao University, Qingdao University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liya","family":"Cui","sequence":"additional","affiliation":[{"name":"The Affiliated Hospital of Qingdao University, Qingdao University","place":["Qingdao, China"]},{"name":"Qingdao Cancer Institute, Qingdao University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[{"name":"The Affiliated Hospital of Qingdao University, Qingdao University","place":["Qingdao, China"]},{"name":"Qingdao Cancer Institute, Qingdao University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[{"name":"The Affiliated Hospital of Qingdao University, Qingdao University","place":["Qingdao, China"]},{"name":"Qingdao Cancer Institute, Qingdao University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"issue":"5","key":"e_1_3_3_2_1","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1021\/acs.jmedchem.2c02115","article-title":"Design, synthesis, and biological evaluation of heterocyclic-fused pyrimidine chemotypes guided by X-ray crystal structure with potential antitumor and anti-multidrug resistance efficacy targeting the colchicine binding site","volume":"66","author":"Tan L","year":"2023","unstructured":"Tan L, Wu C, Zhang J, Yu Q, Wang X, Zhang L, Ge M, Wang Z, Ouyang L, Wang Y. Design, synthesis, and biological evaluation of heterocyclic-fused pyrimidine chemotypes guided by X-ray crystal structure with potential antitumor and anti-multidrug resistance efficacy targeting the colchicine binding site. J Med Chem. 2023;66(5):3588\u20133620.","journal-title":"J Med Chem"},{"key":"e_1_3_3_3_1","doi-asserted-by":"crossref","first-page":"216046","DOI":"10.1016\/j.canlet.2022.216046","article-title":"SB226, an inhibitor of tubulin polymerization, inhibits paclitaxel-resistant melanoma growth and spontaneous metastasis","volume":"555","author":"Deng S","year":"2023","unstructured":"Deng S, Banerjee S, Chen H, Pochampally S, Wang Y, Yun MK, White SW, Parmar K, Meibohm B, Hartman KL, et al. SB226, an inhibitor of tubulin polymerization, inhibits paclitaxel-resistant melanoma growth and spontaneous metastasis. Cancer Lett. 2023;555:216046.","journal-title":"Cancer Lett"},{"key":"e_1_3_3_4_1","doi-asserted-by":"crossref","first-page":"115085","DOI":"10.1016\/j.ejmech.2022.115085","article-title":"Discovery and biological evaluation of 4,6-pyrimidine analogues with potential anticancer agents as novel colchicine binding site inhibitors","volume":"248","author":"Zhang J","year":"2023","unstructured":"Zhang J, Tan L, Wu C, Li Y, Chen H, Liu Y, Wang Y. Discovery and biological evaluation of 4,6-pyrimidine analogues with potential anticancer agents as novel colchicine binding site inhibitors. Eur J Med Chem. 2023;248:115085.","journal-title":"Eur J Med Chem"},{"issue":"2","key":"e_1_3_3_5_1","doi-asserted-by":"crossref","first-page":"118356","DOI":"10.1016\/j.ejmech.2025.118356","article-title":"Novel imidazo[1,2-a]pyridine-based tubulin polymerization inhibitors: Structure-activity relationships and anti-tumor immune potentiation","volume":"302","author":"Cheng B","year":"2026","unstructured":"Cheng B, Li C, Yang X, Wu Y, Ruan Y, Ren Y, Su Z, Wan S, Li X, Kong D, et al. Novel imidazo[1,2-a]pyridine-based tubulin polymerization inhibitors: Structure-activity relationships and anti-tumor immune potentiation. Eur J Med Chem. 2026;302(Pt 2):118356.","journal-title":"Eur J Med Chem"},{"issue":"4","key":"e_1_3_3_6_1","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1021\/acsptsci.2c00108","article-title":"Design, synthesis, and biological evaluation of pyrimidine dihydroquinoxalinone derivatives as tubulin colchicine site-binding agents that displayed potent anticancer activity both in vitro and in vivo","volume":"6","author":"Pochampally S","year":"2023","unstructured":"Pochampally S, Hartman KL, Wang R, Wang J, Yun MK, Parmar K, Park H, Meibohm B, White SW, Li W, et al. Design, synthesis, and biological evaluation of pyrimidine dihydroquinoxalinone derivatives as tubulin colchicine site-binding agents that displayed potent anticancer activity both in vitro and in vivo. ACS Pharmacol Transl Sci. 2023;6(4):526\u2013545.","journal-title":"ACS Pharmacol Transl Sci"},{"key":"e_1_3_3_7_1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejmech.2014.09.051","article-title":"Recent developments in tubulin polymerization inhibitors: An overview","volume":"87","author":"Kaur R","year":"2014","unstructured":"Kaur R, Kaur G, Gill RK, Soni R, Bariwal J. Recent developments in tubulin polymerization inhibitors: An overview. Eur J Med Chem. 2014;87:89\u2013124.","journal-title":"Eur J Med Chem"},{"issue":"1","key":"e_1_3_3_8_1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF02940301","article-title":"Differential cytotoxicity of combretastatins A1 and A4 in two daunorubicin-resistant P388 cell lines","volume":"26","author":"McGown AT","year":"1990","unstructured":"McGown AT, Fox BW. Differential cytotoxicity of combretastatins A1 and A4 in two daunorubicin-resistant P388 cell lines. Cancer Chemother Pharmacol. 1990;26(1):79\u201381.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"e_1_3_3_9_1","first-page":"1433","article-title":"Oxi4503, a novel vascular targeting agent: effects on blood flow and antitumor activity in comparison to combretastatin A-4 phosphate","volume":"23","author":"Hua J","year":"2003","unstructured":"Hua J, Sheng Y, Pinney KG, Garner CM, Kane RR, Prezioso JA, Pettit GR, Chaplin DJ, Edvardsen K. Oxi4503, a novel vascular targeting agent: effects on blood flow and antitumor activity in comparison to combretastatin A-4 phosphate. Anticancer Res. 2003;23(2B):1433\u20131440.","journal-title":"Anticancer Res"},{"issue":"6","key":"e_1_3_3_10_1","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1007\/s10637-014-0119-0","article-title":"Phase I clinical and pharmacokinetic study of ombrabulin (AVE8062) combined with cisplatin\/docetaxel or carboplatin\/paclitaxel in patients with advanced solid tumors","volume":"32","author":"Bahleda R","year":"2014","unstructured":"Bahleda R, Sessa C, Del Conte G, Gianni L, Capri G, Varga A, Oprea C, Daglish B, Hospitel M, Soria JC. Phase I clinical and pharmacokinetic study of ombrabulin (AVE8062) combined with cisplatin\/docetaxel or carboplatin\/paclitaxel in patients with advanced solid tumors. Invest New Drugs. 2014;32(6):1188\u20131196.","journal-title":"Invest New Drugs"},{"key":"e_1_3_3_11_1","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ejmech.2018.09.045","article-title":"Conformation impacts on the bioactivities of SMART analogues","volume":"158","author":"Wu Y","year":"2018","unstructured":"Wu Y, Guan Q, Zheng D, Yan P, Feng D, Du J, Zhang J, Zuo D, Bao K, Zhang W. Conformation impacts on the bioactivities of SMART analogues. Eur J Med Chem. 2018;158:733\u2013742.","journal-title":"Eur J Med Chem"},{"issue":"17","key":"e_1_3_3_12_1","doi-asserted-by":"crossref","first-page":"7877","DOI":"10.1021\/acs.jmedchem.8b00827","article-title":"Structural modification of the 3,4,5-trimethoxyphenyl moiety in the tubulin inhibitor VERU-111 leads to improved antiproliferative activities","volume":"61","author":"Wang Q","year":"2018","unstructured":"Wang Q, Arnst KE, Wang Y, Kumar G, Ma D, Chen H, Wu Z, Yang J, White SW, Miller DD, et al. Structural modification of the 3,4,5-trimethoxyphenyl moiety in the tubulin inhibitor VERU-111 leads to improved antiproliferative activities. J Med Chem. 2018;61(17):7877\u20137891.","journal-title":"J Med Chem"},{"issue":"12","key":"e_1_3_3_13_1","doi-asserted-by":"crossref","first-page":"5865","DOI":"10.1158\/0008-5472.CAN-07-0127","article-title":"MPC-6827: a small-molecule inhibitor of microtubule formation that is not a substrate for multidrug resistance pumps","volume":"67","author":"Kasibhatla S","year":"2007","unstructured":"Kasibhatla S, Baichwal V, Cai SX, Roth B, Skvortsova I, Skvortsov S, Lukas P, English NM, Sirisoma N, Drewe J, et al. MPC-6827: a small-molecule inhibitor of microtubule formation that is not a substrate for multidrug resistance pumps. Cancer Res. 2007;67(12):5865\u20135871.","journal-title":"Cancer Res"},{"issue":"10","key":"e_1_3_3_14_1","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2174\/1871520616666160219161921","article-title":"Recent advances in heterocyclic tubulin inhibitors targeting the colchicine binding site","volume":"16","author":"Wu X","year":"2016","unstructured":"Wu X, Wang Q, Li W. Recent advances in heterocyclic tubulin inhibitors targeting the colchicine binding site. Anticancer Agents Med Chem. 2016;16(10):1325\u20131338.","journal-title":"Anticancer Agents Med Chem"},{"issue":"1","key":"e_1_3_3_15_1","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1080\/14756366.2021.1883598","article-title":"Discovery of new quinolines as potent colchicine binding site inhibitors: design, synthesis, docking studies, and anti-proliferative evaluation","volume":"36","author":"Hagras M","year":"2021","unstructured":"Hagras M, El Deeb MA, Elzahabi HSA, Elkaeed EB, Mehany ABM, Eissa IH. Discovery of new quinolines as potent colchicine binding site inhibitors: design, synthesis, docking studies, and anti-proliferative evaluation. J Enzyme Inhib Med Chem. 2021;36(1):640\u2013658.","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"32","key":"e_1_3_3_16_1","doi-asserted-by":"crossref","first-page":"29448","DOI":"10.1021\/acsomega.3c02979","article-title":"Effect of colchicine binding site inhibitors on the tubulin intersubunit interaction","volume":"8","author":"Sargsyan A","year":"2023","unstructured":"Sargsyan A, Sahakyan H, Nazaryan K. Effect of colchicine binding site inhibitors on the tubulin intersubunit interaction. ACS Omega. 2023;8(32):29448\u201329454.","journal-title":"ACS Omega"},{"issue":"19","key":"e_1_3_3_17_1","doi-asserted-by":"crossref","first-page":"19908","DOI":"10.1021\/acs.jmedchem.5c00014","article-title":"Discovery of novel 4,5-dihydropyrrolo[3,4-c]pyrazol-6(2H)-one-based tubulin inhibitors targeting colchicine binding site with potent anti-ovarian cancer activity","volume":"68","author":"Yu Q","year":"2025","unstructured":"Yu Q, Liu Y, Wang Z, Wu C, Zhang R, Tan L, Zhang L, Guo C, Gou L, Li W, et al. Discovery of novel 4,5-dihydropyrrolo[3,4-c]pyrazol-6(2H)-one-based tubulin inhibitors targeting colchicine binding site with potent anti-ovarian cancer activity. J Med Chem. 2025;68(19):19908\u201319932.","journal-title":"J Med Chem"},{"key":"e_1_3_3_18_1","doi-asserted-by":"crossref","first-page":"118395","DOI":"10.1016\/j.ejmech.2025.118395","article-title":"Synthesis and biological evaluation of polymethoxy homoisoflavanones as tubulin polymerization inhibitors","volume":"303","author":"Yin H","year":"2026","unstructured":"Yin H, Long J, Kong Y, Yin X, Liu Y, Xu Y, Nie Y, Liu X, Tang Y, Shi X, et al. Synthesis and biological evaluation of polymethoxy homoisoflavanones as tubulin polymerization inhibitors. Eur J Med Chem. 2026;303:118395.","journal-title":"Eur J Med Chem"},{"key":"e_1_3_3_19_1","doi-asserted-by":"crossref","first-page":"116869","DOI":"10.1016\/j.ejmech.2024.116869","article-title":"Discovery and biological evaluation of 6-aryl-4-(3,4,5-trimethoxyphenyl)quinoline derivatives with promising antitumor activities as novel colchicine-binding site inhibitors","volume":"279","author":"Xu Q","year":"2024","unstructured":"Xu Q, Tu Y, Zhang Y, Xiu Y, Yu Z, Jiang H, Wang C. Discovery and biological evaluation of 6-aryl-4-(3,4,5-trimethoxyphenyl)quinoline derivatives with promising antitumor activities as novel colchicine-binding site inhibitors. Eur J Med Chem. 2024;279:116869.","journal-title":"Eur J Med Chem"},{"key":"e_1_3_3_20_1","doi-asserted-by":"crossref","first-page":"113826","DOI":"10.1016\/j.ejmech.2021.113826","article-title":"Design, synthesis and bioevaluation of 6-aryl-1-(3,4,5-trimethoxyphenyl)-1H-benzo[d]imidazoles as tubulin polymerization inhibitors","volume":"226","author":"Liu R","year":"2021","unstructured":"Liu R, Huang M, Zhang S, Li L, Li M, Sun J, Wu L, Guan Q, Zhang W. Design, synthesis and bioevaluation of 6-aryl-1-(3,4,5-trimethoxyphenyl)-1H-benzo[d]imidazoles as tubulin polymerization inhibitors. Eur J Med Chem. 2021;226:113826.","journal-title":"Eur J Med Chem"},{"key":"e_1_3_3_21_1","doi-asserted-by":"crossref","first-page":"118405","DOI":"10.1016\/j.ejmech.2025.118405","article-title":"Design, synthesis, and biological evaluation of 2-(benzylthio)-5-(indol-3-yl)-1,3,4-oxadiazole derivatives as tubulin polymerization inhibitors with potential anti-cancer effects","volume":"303","author":"Yang B","year":"2026","unstructured":"Yang B, Man RJ, Xie Q, You J, Shi JY, Dai H, Zhu HL. Design, synthesis, and biological evaluation of 2-(benzylthio)-5-(indol-3-yl)-1,3,4-oxadiazole derivatives as tubulin polymerization inhibitors with potential anti-cancer effects. Eur J Med Chem. 2026;303:118405.","journal-title":"Eur J Med Chem"},{"key":"e_1_3_3_22_1","doi-asserted-by":"crossref","first-page":"105220","DOI":"10.1016\/j.bioorg.2021.105220","article-title":"Design, synthesis and bioevaluation of 2,7-diaryl-pyrazolo[1,5-a]pyrimidines as tubulin polymerization inhibitors","volume":"115","author":"Liu R","year":"2021","unstructured":"Liu R, Zhang S, Huang M, Guo Z, Li L, Li M, Wu L, Guan Q, Zhang W. Design, synthesis and bioevaluation of 2,7-diaryl-pyrazolo[1,5-a]pyrimidines as tubulin polymerization inhibitors. Bioorg Chem. 2021;115:105220.","journal-title":"Bioorg Chem"},{"issue":"19","key":"e_1_3_3_23_1","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.1021\/acs.jmedchem.3c00483","article-title":"Identification of GDC-1971 (RLY-1971), a SHP2 inhibitor designed for the treatment of solid tumors","volume":"66","author":"Taylor AM","year":"2023","unstructured":"Taylor AM, Williams BR, Giordanetto F, Kelley EH, Lescarbeau A, Shortsleeves K, Tang Y, Walters WP, Arrazate A, Bowman C, et al. Identification of GDC-1971 (RLY-1971), a SHP2 inhibitor designed for the treatment of solid tumors. J Med Chem. 2023;66(19):13384\u201313399.","journal-title":"J Med Chem"},{"issue":"5","key":"e_1_3_3_24_1","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1021\/acsmedchemlett.3c00059","article-title":"Discovery of a novel series of potent SHP2 allosteric inhibitors","volume":"14","author":"Petrocchi A","year":"2023","unstructured":"Petrocchi A, Grillo A, Ferrante L, Randazzo P, Prandi A, De Matteo M, Iaccarino C, Bisbocci M, Cellucci A, Alli C, et al. Discovery of a novel series of potent SHP2 allosteric inhibitors. ACS Med Chem Lett. 2023;14(5):645\u2013651.","journal-title":"ACS Med Chem Lett"},{"issue":"4","key":"e_1_3_3_25_1","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1021\/acs.jmedchem.8b01725","article-title":"Optimization of fused bicyclic allosteric SHP2 inhibitors","volume":"62","author":"Bagdanoff JT","year":"2019","unstructured":"Bagdanoff JT, Chen Z, Acker M, Chen YN, Chan H, Dore M, Firestone B, Fodor M, Fortanet J, Hentemann M, et al. Optimization of fused bicyclic allosteric SHP2 inhibitors. J Med Chem. 2019;62(4):1781\u20131792.","journal-title":"J Med Chem"},{"issue":"7","key":"e_1_3_3_26_1","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1021\/acs.oprd.4c00047","article-title":"Scalable synthesis of 6-chloro-1H-pyrazolo[3,4-b]pyrazine via a continuous flow formylation\/hydrazine cyclization cascade","volume":"28","author":"Bass TM","year":"2024","unstructured":"Bass TM, Zell D, Kelly SM, Malig TC, Napolitano JG, Sirois LE, Han C, Gosselin F. Scalable synthesis of 6-chloro-1H-pyrazolo[3,4-b]pyrazine via a continuous flow formylation\/hydrazine cyclization cascade. Org Process Res Dev. 2024;28(7):2635\u20132645.","journal-title":"Org Process Res Dev"},{"key":"e_1_3_3_27_1","doi-asserted-by":"crossref","first-page":"118827","DOI":"10.1016\/j.ejmech.2026.118827","article-title":"Design, synthesis, and biological evaluation of 6-aryl-1-(3,4,5-trimethoxyphenyl)-1H-pyrazolo[4,3-c]pyridine derivatives targeting the colchicine-binding site as new tubulin inhibitors","volume":"311","author":"Guo Z","year":"2026","unstructured":"Guo Z, Liu C, Zhang Y, Xu Q, Cui L, Chen W, Wang C. Design, synthesis, and biological evaluation of 6-aryl-1-(3,4,5-trimethoxyphenyl)-1H-pyrazolo[4,3-c]pyridine derivatives targeting the colchicine-binding site as new tubulin inhibitors. Eur J Med Chem. 2026;311:118827.","journal-title":"Eur J Med Chem"},{"issue":"1","key":"e_1_3_3_28_1","doi-asserted-by":"crossref","first-page":"2302320","DOI":"10.1080\/14756366.2024.2302320","article-title":"Design, synthesis, and bioevaluation of 1h-pyrrolo[3,2-c]pyridine derivatives as colchicine-binding site inhibitors with potent anticancer activities","volume":"39","author":"Wang C","year":"2024","unstructured":"Wang C, Zhang Y, Yang S, Shi L, Rong R, Zhang T, Wu Y, Xing D. Design, synthesis, and bioevaluation of 1h-pyrrolo[3,2-c]pyridine derivatives as colchicine-binding site inhibitors with potent anticancer activities. J Enzyme Inhib Med Chem. 2024;39(1):2302320.","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"1","key":"e_1_3_3_29_1","doi-asserted-by":"crossref","first-page":"2286939","DOI":"10.1080\/14756366.2023.2286939","article-title":"3-aryl-4-(3,4,5-trimethoxyphenyl)pyridines inhibit tubulin polymerisation and act as anticancer agents","volume":"39","author":"Wang C","year":"2024","unstructured":"Wang C, Zhang Y, Yang S, Shi L, Xiu Y, Wu Y, Jiang H. 3-aryl-4-(3,4,5-trimethoxyphenyl)pyridines inhibit tubulin polymerisation and act as anticancer agents. J Enzyme Inhib Med Chem. 2024;39(1):2286939.","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"1","key":"e_1_3_3_30_1","doi-asserted-by":"crossref","first-page":"2595401","DOI":"10.1080\/14756366.2025.2595401","article-title":"Design, synthesis, and biological evaluation of novel 3-aryl-4-(3,4,5-trimethoxyphenyl)selenophene derivatives as new tubulin inhibitors","volume":"40","author":"Xu W","year":"2025","unstructured":"Xu W, Zhang Y, Xu Q, Zhao H, Gao Q, Zhao X, Jiang H, Wang C. Design, synthesis, and biological evaluation of novel 3-aryl-4-(3,4,5-trimethoxyphenyl)selenophene derivatives as new tubulin inhibitors. J Enzyme Inhib Med Chem. 2025;40(1):2595401.","journal-title":"J Enzyme Inhib Med Chem"}],"container-title":["Journal of Enzyme Inhibition and Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14756366.2026.2717975","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14756366.2026.2717975","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14756366.2026.2717975","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T10:57:52Z","timestamp":1787223472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14756366.2026.2717975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/14756366.2026.2717975"],"URL":"https:\/\/doi.org\/10.1080\/14756366.2026.2717975","relation":{},"ISSN":["1475-6366","1475-6374"],"issn-type":[{"value":"1475-6366","type":"print"},{"value":"1475-6374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ienz20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ienz20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-05-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-18","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2717975"}}